Quent Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Quent Capital's RGEN Position: Q1 2026 in Review
Quent Capital reduced its Repligen (RGEN) stake by 74% in Q1 2026, selling an estimated $7.26K and leaving 18 shares worth $2.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1386.
Quent Capital first reported a position in RGEN in Q4 2023 and has held it in 9 quarters since. The position peaked at $11.5K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Quent Capital held 18 shares of Repligen worth $2.12K as of Q1 2026.
- Quent Capital sold 52 Repligen shares in Q1 2026, an estimated $7.26K.
- Repligen made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #1386 holding.
- Quent Capital first reported a position in Repligen in Q4 2023 and has held it in 9 quarters since.
- Quent Capital's Repligen position peaked at $11.5K in Q4 2025.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.